People: Astellas Pharma Inc (ALPMY.PK)
ALPMY.PK on OTC Markets Group
12.99USD
3:28pm EDT
12.99USD
3:28pm EDT
Price Change (% chg)
$0.10 (+0.78%)
$0.10 (+0.78%)
Prev Close
$12.89
$12.89
Open
$13.14
$13.14
Day's High
$13.22
$13.22
Day's Low
$12.99
$12.99
Volume
13,120
13,120
Avg. Vol
101,262
101,262
52-wk High
$14.65
$14.65
52-wk Low
$9.99
$9.99
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
Masafumi Nogimori |
65 | 2011 | Chairman of the Board, Representative Director |
Yoshihiko Hatanaka |
56 | 2011 | President, Representative Director |
Yasuo Ishii |
65 | 2011 | Vice Chairman of the Board, Representative Director |
Masao Yoshida |
Senior Executive Officer, President and CEO of Subsidiaries | ||
Yoshiro Miyokawa |
60 | 2013 | Vice President, Representative Director |
Yukihiko Sato |
Executive Officer, Chief Director of Sales | ||
Yoshiaki Nakashima |
Executive Officer, Director of Human Resources | ||
Masaki Doi |
Executive Officer, Manager of Vaccine Business Promotion Office | ||
Haruhisa Hirosaki |
Executive Officer, Chief Director of Development | ||
Takahisa Iizuka |
Executive Officer, Director of Sales Promotion | ||
Toshihiko Iwata |
Executive Officer, Manager of North Osaka Office in Main Sales Unit | ||
Atsushi Kamide |
Executive Officer, Director of Product Management in Main Sales Unit | ||
Shinichiro Katayanagi |
Executive Officer, Chief Director of Asia Business | ||
Masatoshi Kuroda |
Executive Officer, President of Subsidiary | ||
Mitsunori Matsuda |
Executive Officer, Chief Director of Technology | ||
Yoshihiro Minami |
Executive Officer, Director of Pharmaceutical Affairs in Main Reliability Assurance Unit | ||
Hirofumi Seki |
Executive Officer, Senior Director of Supply Chain | ||
Hidetoshi Shuto |
Executive Officer, Director of Clinical Management in Main Development Unit | ||
Kenji Sumi |
Executive Officer, Manager of East Tokyo Office in Main Sales Unit | ||
Makoto Takeuchi |
Executive Officer, Director of Research Promotion | ||
Wataru Uchida |
Executive Officer, Director of Pharmacology Research Institute in Main Research Unit | ||
Chihiro Yokota |
Executive Officer, Director of Licensing and Alliance | ||
Shoji Yokota |
Executive Officer, Director of Technology Development Promotion in Main Technology Unit | ||
Masaharu Asano |
Senior Executive Officer, Chief Director of Reliability Assurance | ||
Masaru Imahori |
Senior Executive Officer, Director of Public Relations | ||
Yasumasa Masuda |
Senior Executive Officer | ||
Shinichi Tsukamoto |
Senior Executive Officer, Chief Director of Research | ||
Kenji Yasukawa |
Senior Executive Officer | ||
Naoki Aikawa |
69 | 2011 | Independent Director |
Yutaka Kase |
66 | 2013 | Independent Director |
Kanoko Ohishi |
52 | 2010 | Independent Director |
Yasuyuki Takai |
65 | 2009 | Independent Director |
Hironobu Yasuda |
62 | 2013 | Independent Director |
Shiro Yasutake |
71 | 2009 | Independent Director |
Yuichi Murakami |
Director of Accounting |
Biographies
| Name | Description |
|---|---|
Masafumi Nogimori |
Mr. Masafumi Nogimori has been serving as Chairman of the Board and Representative Director in Astellas Pharma Inc., since June 20, 2011. His previous titles include Chief Executive Officer, President and Vice President in the Company. He used to work for Fujisawa Pharmaceutical Co., Ltd., and serve as President in another company. He obtained his bachelor's in Medicine from the University of Tokyo in March 1970. |
Yoshihiko Hatanaka |
Mr. Yoshihiko Hatanaka has been serving as President and Representative Director in Astellas Pharma Inc. since June 20, 2011. He previously served as Executive Officer and Senior Executive Officer in the Company, as well as President and Chief Executive Officer in two US-based subsidiaries. He used to work for Fujisawa Pharmaceutical Co., Ltd. He obtained his bachelor's degree in Economics from Hitotsubashi University in May 1980. |
Yasuo Ishii |
Mr. Yasuo Ishii resigned from the position of Vice Chairman of the Board and Representative Director of Astellas Pharma Inc., effective June 19, 2013. He used to serve as Managing Executive Officer and Vice President in the Company, and previously served as Chairman of the Board of a Europe-based company and a United Kingdom-based company, as well as Chairman of the Board and Chief Executive Officer of a subsidiary of the Company. He also used to work for a Japan-based company. Mr. Ishii obtained his Bachelor's degree in Medicine from The University of Tokyo in March 1970. |
Masao Yoshida |
|
Yoshiro Miyokawa |
Mr. Yoshiro Miyokawa was named Vice President and Representative Director of Astellas Pharma Inc. effective June 19, 2013. Prior to that, he served as Executive Vice President in the Company. He used to be Executive Officer, Senior Executive Officer, Director of Business Innovation, Director of Human Resources in Main Business Administration Unit, Director of Human Resources and Manager of Career Development Office in the Company. He worked for Yamanouchi Pharmaceutical Co., Ltd., before joining the Company. He graduated from Rikkyo University with a Bachelor's degree in Economics in March 1975. |
Yukihiko Sato |
|
Yoshiaki Nakashima |
|
Masaki Doi |
|
Haruhisa Hirosaki |
|
Takahisa Iizuka |
|
Toshihiko Iwata |
|
Atsushi Kamide |
|
Shinichiro Katayanagi |
|
Masatoshi Kuroda |
|
Mitsunori Matsuda |
|
Yoshihiro Minami |
|
Hirofumi Seki |
|
Hidetoshi Shuto |
|
Kenji Sumi |
|
Makoto Takeuchi |
|
Wataru Uchida |
|
Chihiro Yokota |
|
Shoji Yokota |
|
Masaharu Asano |
|
Masaru Imahori |
|
Yasumasa Masuda |
|
Shinichi Tsukamoto |
|
Kenji Yasukawa |
|
Naoki Aikawa |
Mr. Naoki Aikawa has been serving as Independent Director in Astellas Pharma Inc. since June 20, 2011. He is also working for Keio University as Emeritus Professor and Saiseikai Central Hospital. He used to work for Harvard Medical School. |
Yutaka Kase |
Mr. Yutaka Kase was named Independent Director of Astellas Pharma Inc., effective June 19, 2013. He is Chairman of the Board and Representative Director of Sojitz Corporation. He used to work for a company that now became Sojitz Corporation. |
Kanoko Ohishi |
Ms. Kanoko Ohishi has been serving as Independent Director in Astellas Pharma Inc., since June 23, 2010. She is also working for two other companies as Representative Director. She used to work for Nippon Life Insurance Company and McKinsey & Company. |
Yasuyuki Takai |
Mr. Yasuyuki Takai resigned from the position of Independent Director in Astellas Pharma Inc., effective June 19, 2013. He is serving as Guest Professor in Aoyama Gakuin University, and working for a law office. He used to work for The Tokyo District Public Prosecutors Office and The Osaka District Public Prosecutors Office. |
Hironobu Yasuda |
Mr. Hironobu Yasuda was named Independent Director of Astellas Pharma Inc., effective June 19, 2013. He is also working for a law firm. He used to work for Tokyo High Public Prosecutors Office, Tokyo District Public Prosecutor's Office, Yamaguchi District Public Prosecutors Office and Supreme Public Prosecutors Office. He is a lawyer. |
Shiro Yasutake |
Mr. Shiro Yasutake resigned from the position of Independent Director in Astellas Pharma Inc., effective June 19, 2013. He used to work for NISSHOCo. and another company. |
Yuichi Murakami |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
Masafumi Nogimori |
-- |
Yoshihiko Hatanaka |
-- |
Yasuo Ishii |
-- |
Masao Yoshida |
-- |
Yoshiro Miyokawa |
-- |
Yukihiko Sato |
-- |
Yoshiaki Nakashima |
-- |
Masaki Doi |
-- |
Haruhisa Hirosaki |
-- |
Takahisa Iizuka |
-- |
Toshihiko Iwata |
-- |
Atsushi Kamide |
-- |
Shinichiro Katayanagi |
-- |
Masatoshi Kuroda |
-- |
Mitsunori Matsuda |
-- |
Yoshihiro Minami |
-- |
Hirofumi Seki |
-- |
Hidetoshi Shuto |
-- |
Kenji Sumi |
-- |
Makoto Takeuchi |
-- |
Wataru Uchida |
-- |
Chihiro Yokota |
-- |
Shoji Yokota |
-- |
Masaharu Asano |
-- |
Masaru Imahori |
-- |
Yasumasa Masuda |
-- |
Shinichi Tsukamoto |
-- |
Kenji Yasukawa |
-- |
Naoki Aikawa |
-- |
Yutaka Kase |
-- |
Kanoko Ohishi |
-- |
Yasuyuki Takai |
-- |
Hironobu Yasuda |
-- |
Shiro Yasutake |
-- |
Yuichi Murakami |
-- |
As Of
Options Compensation
| Name | Options | Value |
|---|---|---|
Masafumi Nogimori |
0 | 0 |
Yoshihiko Hatanaka |
0 | 0 |
Yasuo Ishii |
0 | 0 |
Masao Yoshida |
0 | 0 |
Yoshiro Miyokawa |
0 | 0 |
Yukihiko Sato |
0 | 0 |
Yoshiaki Nakashima |
0 | 0 |
Masaki Doi |
0 | 0 |
Haruhisa Hirosaki |
0 | 0 |
Takahisa Iizuka |
0 | 0 |
Toshihiko Iwata |
0 | 0 |
Atsushi Kamide |
0 | 0 |
Shinichiro Katayanagi |
0 | 0 |
Masatoshi Kuroda |
0 | 0 |
Mitsunori Matsuda |
0 | 0 |
Yoshihiro Minami |
0 | 0 |
Hirofumi Seki |
0 | 0 |
Hidetoshi Shuto |
0 | 0 |
Kenji Sumi |
0 | 0 |
Makoto Takeuchi |
0 | 0 |
Wataru Uchida |
0 | 0 |
Chihiro Yokota |
0 | 0 |
Shoji Yokota |
0 | 0 |
Masaharu Asano |
0 | 0 |
Masaru Imahori |
0 | 0 |
Yasumasa Masuda |
0 | 0 |
Shinichi Tsukamoto |
0 | 0 |
Kenji Yasukawa |
0 | 0 |
Naoki Aikawa |
0 | 0 |
Yutaka Kase |
0 | 0 |
Kanoko Ohishi |
0 | 0 |
Yasuyuki Takai |
0 | 0 |
Hironobu Yasuda |
0 | 0 |
Shiro Yasutake |
0 | 0 |
Yuichi Murakami |
0 | 0 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
